Skip to main content
Erschienen in: Inflammation 1/2023

29.09.2022 | Original Article

Pyruvate Dehydrogenase Kinase 2 Accelerates Endotoxin Shock by Promoting Mitogen-Activated Protein Kinase Activation

verfasst von: Chunxia Li, Jun Dai, Chuanbin Liu, Guanjun Dong, Xin Zhang, Junfeng Zhang, Fenglian Yan, Hui Zhang, Changying Wang, Mingsheng Zhao, Zhaochen Ning, Qun Ma, Hui Shi, Zhihua Li, Huabao Xiong

Erschienen in: Inflammation | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Endotoxin shock remains one of the major causes of mortality worldwide. Pyruvate dehydrogenase kinase (PDK) 2 is an important regulatory enzyme involved in glucose metabolism. The purpose of this study was to determine the regulatory effect of PDK2 on LPS-induced endotoxin shock and explore the mechanisms in vivo and in vitro. Here, we showed that PDK2 contributed to Toll-like receptor (TLR)-mediated inflammation. Lipopolysaccharide (LPS) activation of TLR4 pathways resulted in PDK2 upregulation in macrophages and dendritic cells (DCs). PDK2 overexpression enhanced TLR4 signaling pathway activation, whereas downregulating PDK2 expression inhibited TLR4 signaling pathway activation. Pharmacological inhibition of PDK2 significantly decreased the mortality rate and alleviated pathological injury in the lungs and livers of LPS-challenged mice, while significantly suppressing proinflammatory cytokine production. Thus, we confirmed that PDK2 is involved in LPS-induced endotoxin shock by modulating TLR4-mitogen-activated protein kinase signaling and inducing the production of proinflammatory cytokines in macrophages and DCs. Our findings highlight the importance of PDK2 as a novel target to treat septic shock.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. Bellomo, G.R. Bernard, J.D. Chiche, C.M. Coopersmith, R.S. Hotchkiss, M.M. Levy, J.C. Marshall, G.S. Martin, S.M. Opal, G.D. Rubenfeld, T. van der Poll, J.L. Vincent, and D.C. Angus. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315: 801–810. https://doi.org/10.1001/jama.2016.0287.CrossRefPubMedPubMedCentral Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. Bellomo, G.R. Bernard, J.D. Chiche, C.M. Coopersmith, R.S. Hotchkiss, M.M. Levy, J.C. Marshall, G.S. Martin, S.M. Opal, G.D. Rubenfeld, T. van der Poll, J.L. Vincent, and D.C. Angus. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315: 801–810. https://​doi.​org/​10.​1001/​jama.​2016.​0287.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat de Padua Lucio K., A.C.S. Rabelo, C.M. Araujo, G.C. Brandao, G.H.B. de Souza, R.G. da Silva, D.M.S. de Souza, A. Talvani, F.S. Bezerra, A.J. Cruz Calsavara, and D.C. Costa. 2018. Anti-inflammatory and antioxidant properties of black mulberry (Morus nigra L.) in a model of LPS-induced sepsis. Oxidative medicine and cellular longevity 2018:5048031. https://doi.org/10.1155/2018/5048031. de Padua Lucio K., A.C.S. Rabelo, C.M. Araujo, G.C. Brandao, G.H.B. de Souza, R.G. da Silva, D.M.S. de Souza, A. Talvani, F.S. Bezerra, A.J. Cruz Calsavara, and D.C. Costa. 2018. Anti-inflammatory and antioxidant properties of black mulberry (Morus nigra L.) in a model of LPS-induced sepsis. Oxidative medicine and cellular longevity 2018:5048031. https://​doi.​org/​10.​1155/​2018/​5048031.
5.
Zurück zum Zitat Napier, B.A., M. Andres-Terre, L.M. Massis, A.J. Hryckowian, S.K. Higginbottom, K. Cumnock, K.M. Casey, B. Haileselassie, K.A. Lugo, D.S. Schneider, J.L. Sonnenburg, and D.M. Monack. 2019. Western diet regulates immune status and the response to LPS-driven sepsis independent of diet-associated microbiome. Proceedings of the National Academy of Sciences of the United States of America 116: 3688–3694. https://doi.org/10.1073/pnas.1814273116.CrossRefPubMedPubMedCentral Napier, B.A., M. Andres-Terre, L.M. Massis, A.J. Hryckowian, S.K. Higginbottom, K. Cumnock, K.M. Casey, B. Haileselassie, K.A. Lugo, D.S. Schneider, J.L. Sonnenburg, and D.M. Monack. 2019. Western diet regulates immune status and the response to LPS-driven sepsis independent of diet-associated microbiome. Proceedings of the National Academy of Sciences of the United States of America 116: 3688–3694. https://​doi.​org/​10.​1073/​pnas.​1814273116.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Li, X., X. Yao, Y. Zhu, H. Zhang, H. Wang, Q. Ma, F. Yan, Y. Yang, J. Zhang, H. Shi, Z. Ning, J. Dai, Z. Li, C. Li, F. Su, Y. Xue, X. Meng, G. Dong, and H. Xiong. 2019. The caspase inhibitor Z-VAD-FMK alleviates endotoxic shock via inducing macrophages necroptosis and promoting MDSCs-mediated inhibition of macrophages activation. Frontiers in immunology 10: 1824. https://doi.org/10.3389/fimmu.2019.01824.CrossRefPubMedPubMedCentral Li, X., X. Yao, Y. Zhu, H. Zhang, H. Wang, Q. Ma, F. Yan, Y. Yang, J. Zhang, H. Shi, Z. Ning, J. Dai, Z. Li, C. Li, F. Su, Y. Xue, X. Meng, G. Dong, and H. Xiong. 2019. The caspase inhibitor Z-VAD-FMK alleviates endotoxic shock via inducing macrophages necroptosis and promoting MDSCs-mediated inhibition of macrophages activation. Frontiers in immunology 10: 1824. https://​doi.​org/​10.​3389/​fimmu.​2019.​01824.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Shin, J.S., K.G. Lee, H.H. Lee, H.J. Lee, H.J. An, J.H. Nam, D.S. Jang, and K.T. Lee. 2016. alpha-Solanine Isolated From Solanum Tuberosum L. cv Jayoung Abrogates LPS-induced inflammatory responses via NF-kappaB inactivation in RAW 264.7 macrophages and endotoxin-induced shock model in mice. Journal of cellular biochemistry 117: 2327–2339. https://doi.org/10.1002/jcb.25530.CrossRefPubMed Shin, J.S., K.G. Lee, H.H. Lee, H.J. Lee, H.J. An, J.H. Nam, D.S. Jang, and K.T. Lee. 2016. alpha-Solanine Isolated From Solanum Tuberosum L. cv Jayoung Abrogates LPS-induced inflammatory responses via NF-kappaB inactivation in RAW 264.7 macrophages and endotoxin-induced shock model in mice. Journal of cellular biochemistry 117: 2327–2339. https://​doi.​org/​10.​1002/​jcb.​25530.CrossRefPubMed
16.
Zurück zum Zitat Go, Y., J.Y. Jeong, N.H. Jeoung, J.H. Jeon, B.Y. Park, H.J. Kang, C.M. Ha, Y.K. Choi, S.J. Lee, H.J. Ham, B.G. Kim, K.G. Park, S.Y. Park, C.H. Lee, C.S. Choi, T.S. Park, W.N. Lee, R.A. Harris, and I.K. Lee. 2016. Inhibition of pyruvate dehydrogenase kinase 2 protects against hepatic steatosis through modulation of tricarboxylic acid cycle anaplerosis and ketogenesis. Diabetes 65: 2876–2887. https://doi.org/10.2337/db16-0223.CrossRefPubMed Go, Y., J.Y. Jeong, N.H. Jeoung, J.H. Jeon, B.Y. Park, H.J. Kang, C.M. Ha, Y.K. Choi, S.J. Lee, H.J. Ham, B.G. Kim, K.G. Park, S.Y. Park, C.H. Lee, C.S. Choi, T.S. Park, W.N. Lee, R.A. Harris, and I.K. Lee. 2016. Inhibition of pyruvate dehydrogenase kinase 2 protects against hepatic steatosis through modulation of tricarboxylic acid cycle anaplerosis and ketogenesis. Diabetes 65: 2876–2887. https://​doi.​org/​10.​2337/​db16-0223.CrossRefPubMed
18.
Zurück zum Zitat He, Z., Z. Li, X. Zhang, K. Yin, W. Wang, Z. Xu, B. Li, L. Zhang, J. Xu, G. Sun, L. Wang, Q. Li, X. Huang, L. Zhang, D. Zhang, H. Xu, and Z. Xu. 2018. MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer. Cell Death & Disease 9: 505. https://doi.org/10.1038/s41419-018-0564-3.CrossRef He, Z., Z. Li, X. Zhang, K. Yin, W. Wang, Z. Xu, B. Li, L. Zhang, J. Xu, G. Sun, L. Wang, Q. Li, X. Huang, L. Zhang, D. Zhang, H. Xu, and Z. Xu. 2018. MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer. Cell Death & Disease 9: 505. https://​doi.​org/​10.​1038/​s41419-018-0564-3.CrossRef
20.
Zurück zum Zitat Min, B.K., S. Park, H.J. Kang, D.W. Kim, H.J. Ham, C.M. Ha, B.J. Choi, J.Y. Lee, C.J. Oh, E.K. Yoo, H.E. Kim, B.G. Kim, J.H. Jeon, D.Y. Hyeon, D. Hwang, Y.H. Kim, C.H. Lee, T. Lee, J.W. Kim, Y.K. Choi, K.G. Park, A. Chawla, J. Lee, R.A. Harris, and I.K. Lee. 2019. Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype. Frontiers in immunology 10: 944. https://doi.org/10.3389/fimmu.2019.00944.CrossRefPubMedPubMedCentral Min, B.K., S. Park, H.J. Kang, D.W. Kim, H.J. Ham, C.M. Ha, B.J. Choi, J.Y. Lee, C.J. Oh, E.K. Yoo, H.E. Kim, B.G. Kim, J.H. Jeon, D.Y. Hyeon, D. Hwang, Y.H. Kim, C.H. Lee, T. Lee, J.W. Kim, Y.K. Choi, K.G. Park, A. Chawla, J. Lee, R.A. Harris, and I.K. Lee. 2019. Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype. Frontiers in immunology 10: 944. https://​doi.​org/​10.​3389/​fimmu.​2019.​00944.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Meyers, A.K., Z. Wang, W. Han, Q. Zhao, M. Zabalawi, J. Liu, R.K. Manne, H.K. Lin, C.M. Furdui, J.W. Locasale, and C.M. McCall. 2021. Pyruvate dehydrogenase kinase supports macrophage NLRP3 inflammasome activation during acute inflammation. Meyers, A.K., Z. Wang, W. Han, Q. Zhao, M. Zabalawi, J. Liu, R.K. Manne, H.K. Lin, C.M. Furdui, J.W. Locasale, and C.M. McCall. 2021. Pyruvate dehydrogenase kinase supports macrophage NLRP3 inflammasome activation during acute inflammation.
25.
Zurück zum Zitat Mayers, R.M., R.J. Butlin, E. Kilgour, B. Leighton, D. Martin, J. Myatt, J.P. Orme, and B.R. Holloway. 2003. AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats. Biochemical Society transactions 31: 1165–1167. https://doi.org/10.1042/bst0311165.CrossRefPubMed Mayers, R.M., R.J. Butlin, E. Kilgour, B. Leighton, D. Martin, J. Myatt, J.P. Orme, and B.R. Holloway. 2003. AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats. Biochemical Society transactions 31: 1165–1167. https://​doi.​org/​10.​1042/​bst0311165.CrossRefPubMed
32.
Zurück zum Zitat Bajotto, G., T. Murakami, M. Nagasaki, B. Qin, Y. Matsuo, K. Maeda, M. Ohashi, Y. Oshida, Y. Sato, and Y. Shimomura. 2006. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: Induction by elevated levels of free fatty acids. Metabolism 55: 317–323. https://doi.org/10.1016/j.metabol.2005.09.014.CrossRefPubMed Bajotto, G., T. Murakami, M. Nagasaki, B. Qin, Y. Matsuo, K. Maeda, M. Ohashi, Y. Oshida, Y. Sato, and Y. Shimomura. 2006. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: Induction by elevated levels of free fatty acids. Metabolism 55: 317–323. https://​doi.​org/​10.​1016/​j.​metabol.​2005.​09.​014.CrossRefPubMed
33.
35.
Zurück zum Zitat de Oliveira, R.G., Castilho G. R. de Campos, A.L. da Cunha, F. Miyajima, and Martins D. T. de Oliveira. 2017. Dilodendron bipinnatum Radlk. inhibits pro-inflammatory mediators through the induction of MKP-1 and the down-regulation of MAPKp38/JNK/NF-kappaB pathways and COX-2 in LPS-activated RAW 264.7 cells. Journal of Ethnopharmacology 202: 127–137. https://doi.org/10.1016/j.jep.2017.02.026.CrossRefPubMed de Oliveira, R.G., Castilho G. R. de Campos, A.L. da Cunha, F. Miyajima, and Martins D. T. de Oliveira. 2017. Dilodendron bipinnatum Radlk. inhibits pro-inflammatory mediators through the induction of MKP-1 and the down-regulation of MAPKp38/JNK/NF-kappaB pathways and COX-2 in LPS-activated RAW 264.7 cells. Journal of Ethnopharmacology 202: 127–137. https://​doi.​org/​10.​1016/​j.​jep.​2017.​02.​026.CrossRefPubMed
Metadaten
Titel
Pyruvate Dehydrogenase Kinase 2 Accelerates Endotoxin Shock by Promoting Mitogen-Activated Protein Kinase Activation
verfasst von
Chunxia Li
Jun Dai
Chuanbin Liu
Guanjun Dong
Xin Zhang
Junfeng Zhang
Fenglian Yan
Hui Zhang
Changying Wang
Mingsheng Zhao
Zhaochen Ning
Qun Ma
Hui Shi
Zhihua Li
Huabao Xiong
Publikationsdatum
29.09.2022
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01744-8

Weitere Artikel der Ausgabe 1/2023

Inflammation 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.